Metsera Inc (MTSR)

Mar 26, 2025, 7:00 AM EDT - 4 weeks ago

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress

Feb 26, 2025, 7:00 AM EST - 2 months ago

Metsera to Present at TD Cowen's 45th Annual Health Care Conference

Feb 26, 2025, 3:55 AM EST - 2 months ago

Metsera: Capturing Of Obesity Market With Long-Acting GLP-1 Differentiation

Feb 25, 2025, 1:42 PM EST - 2 months ago

Why this newly public biotech could become a force in obesity treatments

Feb 25, 2025, 8:47 AM EST - 2 months ago

This weight-loss drug stock could deliver a 90% return in 2025

Feb 5, 2025, 4:01 PM EST - 2 months ago

Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters' Option to Purchase Additional Shares

Feb 1, 2025, 2:10 AM EST - 2 months ago

U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOs

BBNX CSAI INR MAZE ODTX ODYS SAIL

Jan 31, 2025, 12:42 PM EST - 2 months ago

Weight-loss drug developer Metsera valued at $2.68 bln as shares jumped in market debut

Jan 30, 2025, 7:05 PM EST - 3 months ago

Weight-loss drug developer Metsera raises $275 million in US IPO

Jan 30, 2025, 6:53 PM EST - 3 months ago

Metsera Announces Pricing of Initial Public Offering

Jan 28, 2025, 4:48 PM EST - 3 months ago

Metsera Readies $275 Million IPO For Obesity Treatments

Jan 10, 2025, 6:02 PM EST - 3 months ago

Weight-loss drug developer Metsera reveals wider loss in US IPO filing

Jan 10, 2025, 4:46 PM EST - 3 months ago

Metsera IPO Registration Document (S-1)